Raltitrexed plus oxaliplatin in the second-line treatment of metastatic colorectal cancer
| Main Authors: | Kiss, I. (Author), Kocáková, I. (Author), Jarkovský, J. (Author), Dušek, L. (Author), Demlová, R. (Author), Vyzula, R. (Author) |
|---|---|
| Format: | Article |
| Language: | English |
Predplatné
Kliknite na „Pozri predplatné“.
Similar Items
Cetuximab plus chemotherapy as first-line treatment for metastatic colorectal cancer: Effect of KRAS mutation on treatment efficacy in Taiwanese patients
by: Chiang, F. F., et al.
by: Chiang, F. F., et al.
Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients
by: Uner, A., et al.
by: Uner, A., et al.
New weekly schedule of irinotecan as second line treatment in advanced colorectal cancer
by: Šálek, Tomáš, 1954-, et al.
by: Šálek, Tomáš, 1954-, et al.
Bevacizumab in combination with chemotherapy in the first-line treatment of metastatic colorectal carcinoma
by: Usak, J., et al.
by: Usak, J., et al.
Similar Items
-
Cetuximab plus chemotherapy as first-line treatment for metastatic colorectal cancer: Effect of KRAS mutation on treatment efficacy in Taiwanese patients
by: Chiang, F. F., et al. -
Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients
by: Uner, A., et al. -
New weekly schedule of irinotecan as second line treatment in advanced colorectal cancer
by: Šálek, Tomáš, 1954-, et al. -
Bevacizumab in combination with chemotherapy in the first-line treatment of metastatic colorectal carcinoma
by: Usak, J., et al. -
Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients
by: Weismanová, Eva, 1956-, et al.


